GlaxoSmithKline's mepolizumab to treat patients with severe eosinophilic asthma (12 years & older)
Read MoreJUN 11 PADAC
GlaxoSmithKline's mepolizumab to treat patients with severe eosinophilic asthma (12 years & older)
Read MoreJUN 11 PADAC
GlaxoSmithKline's mepolizumab to treat patients with severe eosinophilic asthma (12 years & older)
Read MoreJUN 11 PADAC
GlaxoSmithKline's mepolizumab to treat patients with severe eosinophilic asthma (12 years & older)
Read MoreMAR 19 PADAC-DSRM
GlaxoSmithKline's Breo Ellipta for asthma in patients 12 years of age and older. Focus is on the adequacy of the safety database.
Read MoreMAR 19 PADAC-DSRM
GlaxoSmithKline's Breo Ellipta for asthma in patients 12 years of age and older. Focus is on the adequacy of the safety database.
Read MoreMAR 19 PADAC-DSRM
GlaxoSmithKline's Breo Ellipta for asthma in patients 12 years of age and older. Focus is on the adequacy of the safety database.
Read More